tiprankstipranks
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market

Petros Pharmaceuticals (PTPI) Income Statement

Compare
138 Followers

Petros Pharmaceuticals Income Statement

Last quarter (Q3 2024), Petros Pharmaceuticals's total revenue was $1.58M, a decrease of -5.87% from the same quarter last year. In Q3, Petros Pharmaceuticals's net income was $-2.22M. See Petros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.82M$ 5.99M$ 7.81M$ 9.56M$ 15.58M
Gross Profit
$ 4.19M$ 3.70M$ 6.21M$ 5.51M$ 8.15M
Operating Expenses
$ 17.81M$ 19.55M$ 24.26M$ 22.80M$ 25.02M
Depreciation and Amortization
$ 3.42M$ 5.72M$ 6.98M$ 6.75M$ 5.32M
EBITDA
$ -4.21M$ -13.73M$ -1.64M$ -12.21M$ -14.00M
Operating Income
$ -13.62M$ -15.85M$ -18.05M$ -17.28M$ -16.87M
Other Income/Expenses
$ 5.45M$ -121.82K$ 9.06M$ -4.73M$ -13.84M
Pretax Income
$ -8.16M$ -20.04M$ -8.99M$ -22.01M$ -33.16M
Net Income
$ -8.16M$ -27.04M$ -9.36M$ -20.59M$ -32.51M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.35$ -13.06$ -8.59$ -21.21$ -190.46
Diluted EPS
$ -6.35$ -13.06$ -8.59$ -21.21$ -190.46
Weighted Average Shares Outstanding
2.18M 2.07M 1.09M 970.76K 170.70K
Weighted Average Shares Outstanding (Diluted)
2.18M 2.07M 1.09M 970.76K 170.70K
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis